Teradyne supplies the testing behind the AI revolution, with fundamentals accelerating and technicals confirming. x.com 

Teradyne is a multiyear compounder as both the cobot layer of factory automation and the test layer for AI chips. Its Universal Robots unit makes collaborative robots that let factories retrofit a line in a weekend instead of a year, and it is the spine of half the factory floors automating in 2026. Its semiconductor test gear is what every AI chip passes through, its own or Advantest's. Forward EPS of $9.51 at 35x anchors fair value at $333, near the current $337.88; the 320s would be a buy. … Show more

Teradyne's Q2 outlook coming in below its Q1 results is concerning when demand should be sky-high, and if later quarters look the same, its P/E would be too high to justify buying. x.com 

Teradyne is trying to push off its 200 EMA and support zone after a stellar Q2. Adjusted EPS was $2.47 versus $2.09 expected and sales $1.329B versus $1.223B, and it raised Q3 EPS and sales guidance. x.com 

Teradyne's test business is surging because rising AI chip complexity multiplies testing demand. Q2 revenue was a record $1.329 billion, up about 104% and above consensus, and Semiconductor Test revenue rose 128% to $1.122 billion. Management said AI is now its primary growth engine, contributing about $1.2 billion of Q2 revenue across compute, HBM and networking. More sophisticated GPUs, ASICs and HBM need far more testing, making its high-end ATE mission-critical. x.com 

Teradyne looks less dominant in CPO testing than expected after it acknowledged Advantest's capabilities on its earnings call. Per GF Securities, low TSMC SoIC yields have led the industry to cut 2026 CPO shipment forecasts, and Teradyne enters a 2H26 transition: Q2 guidance implies a 6% sequential drop, 55-60% of 2026 revenue falls in the first half, and it trades at 47x 2026 earnings. GF still sees long-term CPO upside, with 2027 CPO revenue possibly $800M. x.com  x.com 

Teradyne shows leadership character in two of the hottest themes, semiconductor testing and robotics: it has posted back-to-back strong earnings and every dip to its 50-day moving average gets bought. It also leads industrial automation through Universal Robots and MiR, helping factories automate repetitive, high-precision, labor-heavy tasks. x.com 

Lam Research's strong revenue and free-cash-flow forecasts remain intact despite the selloff, suggesting upside if it delivers. Consensus puts fiscal Q1 revenue at $8.13B; FY2027 revenue is expected at $34.92B, with free cash flow potentially near $10B at a 28.33% margin. Analysts' $375.81-$378.20 targets imply 42.8% upside from $263.94 if FCF forecasts hold. Q1 execution is critical to show whether AI capex strength is translating into cash. x.com 

SiTime is an under-the-radar AI infrastructure winner posting triple-digit growth while likely trading below 40x NTM EPS. Its silicon timing chips replace quartz across data centers, robots, drones, defense and robotaxis. Q3 guidance implies ~250% YoY revenue and ~315% EPS growth; the Renesas deal adds ~$85M, leaving ~30% organic QoQ growth. It sells more into each rack, expects 1.6T optical revenue to double in 2027 with higher share and ASPs, and customers order 12-18 months out. x.com  x.com  … Show more

TSMC belongs in every portfolio because its growth, moat, market dominance and pricing power are unmatched, and ignoring it over China risk is a mistake. It holds about 90% of the advanced-node market, and the AI buildout keeps pulling demand toward the chips it makes best. Even assuming growth slows to 14%, gross margin eases to 63.5% and a 25x exit multiple, the stock reaches $937 by 2031, a 17.75% annual return. Risks include China, rising capex, customer concentration and hyperscaler cuts. … Show more